These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36380529)

  • 1. Perioperative mortality in liver transplantation before and after the implementation of the organ allocation policy Share 35.
    Holm ZD; Kolodzie K; Galli AM; Meyhoff CS; Niemann CU; Adelmann D
    Clin Transplant; 2023 Jan; 37(1):e14854. PubMed ID: 36380529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
    Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
    J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MELD scores of liver transplant recipients according to size of waiting list: impact of organ allocation and patient outcomes.
    Trotter JF; Osgood MJ
    JAMA; 2004 Apr; 291(15):1871-4. PubMed ID: 15100206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the Share 35 Policy on Perioperative Management and Mortality in Liver Transplantation Recipients.
    Lapisatepun W; Agopian VG; Xia VW; Lapisatepun W
    Ann Transplant; 2021 Oct; 26():e932895. PubMed ID: 34711796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reassessing the survival benefit of deceased donor liver transplantation: retrospective cohort study.
    Malamon JS; Kaplan B; Jackson WE; Saben JL; Schold JD; Pomfret EA; Pomposelli JJ
    Int J Surg; 2023 Sep; 109(9):2714-2720. PubMed ID: 37226874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Share 21 model in liver transplantation: Impact on waitlist outcomes.
    Nagai S; Chau LC; Kitajima T; Yeddula S; Collins K; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
    Am J Transplant; 2020 Aug; 20(8):2184-2197. PubMed ID: 32155314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement in the Outcomes of MELD ≥ 40 Liver Transplantation: An Analysis of 207 Consecutive Transplants in a Highly Competitive DSA.
    Nekrasov V; Matsuoka L; Kaur N; Pita A; Whang G; Cao S; Groshen S; Alexopoulos S
    Transplantation; 2017 Oct; 101(10):2360-2367. PubMed ID: 28319564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. National Outcomes of Liver Transplantation for Model for End-Stage Liver Disease Score ≥40: The Impact of Share 35.
    Nekrasov V; Matsuoka L; Rauf M; Kaur N; Cao S; Groshen S; Alexopoulos SP
    Am J Transplant; 2016 Oct; 16(10):2912-2924. PubMed ID: 27063579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of major hepatocellular carcinoma policy changes on liver transplantation for hepatocellular carcinoma in the United States.
    Shah RH; Chyou D; Goldberg DS
    Liver Transpl; 2022 Dec; 28(12):1857-1864. PubMed ID: 35585774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved posttransplant mortality after share 35 for liver transplantation.
    Kwong AJ; Goel A; Mannalithara A; Kim WR
    Hepatology; 2018 Jan; 67(1):273-281. PubMed ID: 28586179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
    Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
    Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Model for end-stage liver disease: did the new liver allocation policy affect waiting list mortality?
    Austin MT; Poulose BK; Ray WA; Arbogast PG; Feurer ID; Pinson CW
    Arch Surg; 2007 Nov; 142(11):1079-85. PubMed ID: 18025337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations Among Different Domains of Quality Among US Liver Transplant Programs.
    Brown CS; Waits SA; Englesbe MJ; Sonnenday CJ; Sheetz KH
    JAMA Netw Open; 2021 Aug; 4(8):e2118502. PubMed ID: 34369991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Same policy, different impact: Center-level effects of share 35 liver allocation.
    Murken DR; Peng AW; Aufhauser DD; Abt PL; Goldberg DS; Levine MH
    Liver Transpl; 2017 Jun; 23(6):741-750. PubMed ID: 28407441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Share 35 liver transplantation allocation in Australia and New Zealand.
    Fink MA; Gow PJ; McCaughan GW; Hodgkinson P; Chen J; McCall J; Jaques B; Crawford M; Strasser SI; Hardikar W; Brooke-Smith M; Starkey G; Jeffrey GP; Gane E; Stormon M; Evans H; Tallis C; Byrne AJ; Jones RM
    Clin Transplant; 2024 Jan; 38(1):e15203. PubMed ID: 38088459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Allocating Livers for Transplantation Based on Model for End-Stage Liver Disease-Sodium Scores on Patient Outcomes.
    Nagai S; Chau LC; Schilke RE; Safwan M; Rizzari M; Collins K; Yoshida A; Abouljoud MS; Moonka D
    Gastroenterology; 2018 Nov; 155(5):1451-1462.e3. PubMed ID: 30056096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should All Status 1A Patients Be Prioritized Over High MELD Patients? Concept of Risk Stratification in Extremely Ill Liver Transplant Recipients.
    Safwan M; Nwagu U; Collins K; Abouljoud M; Nagai S
    Transplantation; 2019 Oct; 103(10):2121-2129. PubMed ID: 30747840
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in liver acceptance patterns after implementation of Share 35.
    Washburn K; Harper A; Baker T; Edwards E
    Liver Transpl; 2016 Feb; 22(2):171-7. PubMed ID: 26437266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.